Black Diamond Therapeutics, Inc. (BDTX) Tops Q4 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BDTX Hot Sheet
Join SI Premium – FREE
Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) reported Q4 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Black Diamond Therapeutics, Inc. (BDTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ACM Research (ACMR) Tops Q3 EPS by 6c ; Offers Guidance
- Comstock Resources (CRK) Misses Q3 EPS by 1c
- Targa Resources (TRGP) Reports Q3 results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
